| |  | | | | By Helen Branswell NIAID The report suggests the U.S. response should transition from one directed solely at Covid to one focused on a number of respiratory viruses. Read More | | By Mohana Ravindranath Dan Kitwood/Getty Images It's not yet clear if Amazon's partnership with Teladoc will address the social and economic barriers to health that underserved groups face. Read More | | By Marcus A. Banks Hassan Ammar/AP Emerging evidence suggests that women also experience greater toxicity with targeted therapies and immunotherapies. Read More | | Sponsor content by STAT Reports How continuous glucose monitors are transforming diabetes care Continuous glucose monitoring, or CGM, is transforming diabetes care. Where a diagnosis once meant a lifetime of finger pricking and injections, these devices now help achieve less invasive monitoring and treatment for the millions of Americans living with diabetes. With prescriptions of CGMs increasing, the question remains — can these devices become the standard of care? Our latest report looks to answer this question, analyzing our best intelligence on the burgeoning industry of CGM, and examining where the industry is likely to head next. | | By Adam Feuerstein Yichuan Cao/Sipa USA via AP Images Gilead chose not to provide any specific data from the Trodelvy study, and it would not say whether the results were clinically meaningful. Read More | | By Tino Delamerced Adobe The researchers theorized that these neurons are involved in cleaving experiences into distinct events that humans can better remember. Read More | | By Nicholas Florko Zach Gibson/Getty Images Rep. Frank Pallone’s new bill would dramatically crack down on the Food and Drug Administration's so-called accelerated approval program. Read More | | By Elizabeth Cooney NIAID A network of Boston hospitals joined RECOVER, a national, NIH-sponsored effort whose mission is to understand, prevent, and treat long Covid. Read More | |
No comments